Delivery Order SPE2DB22D3102-SPE2DB25FL2SR
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,227.66 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose 10s) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical procurement through the agency's medical supply chain. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for UBRELVY 100 mg tablet unit dose packs (16-count) with a ceiling value of $1,488.85. This competitive award, executed under firm fixed-price terms with no set-aside designation, is scheduled for completion by September 2, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (10-count). This competitively awarded, non-set-aside contract carries a ceiling value of $10,509.46 under a firm fixed price arrangement with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,051.65 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose) on September 8, 2025, with completion scheduled for September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 50 mg tablets in unit-dose packaging of 10s. This competitively awarded contract, valued at $9,038.71, carries a firm fixed price and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of UBRELVY 100 mg tablets in unit-dose packaging (10 tablets per package). This is a firm fixed-price delivery order valued at $9,494.44, with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a $3,430.55 delivery order to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (10 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.34 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, operates under a firm fixed price arrangement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a $7,463.51 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of UBRELVY 100 MG tablets (unit dose, 10-count packages). This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,381.64 for UBRELVY 50 MG tablets (10-unit dose packaging) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through...